C4 Flashcards
Antifungal drugs?
9
- Clot.RimaZol (ريما)
- Fluconazol
- Itraconazol
- Voriconazol
- Caspofungin (فنجان)
- Flucytosin
- Terbinafine
- Nystatin
- Amphotericin B
what about Amphotericin B?
Amphotericin B is a polyene Abx related to nystatin
Amphotericin B PharmacoKinetix?
- administered I.V. in 3 forms poorly (absorbed from G.I.T)
1. nonlipid colloidal suspension
2. lipid complex
3. liposomal formulation (less nephrotoxic) - IV for systemic infection
- topical for ocular/bladder infections
- distribution: all tissues (except CNS)
- Elimination: slow hepatic metabolism
( a bit in urine) - 1/2 life: ± weeks
-
Amphotericin MOA?
- fungicidal
- affect the permeability and transport properties of fungal membranes
- bind to Ergosterol (cell membranes) –> leaky pores
- Resistance: uncommon, occurs if membrane ergosterol level or structure decrease
Amphotericin B Clinical uses?
- used for initial induction regimens before Azole
- widest Antifungal spectrum
- drug of choice, or codrug of choice, for most systemic mycosis infection caused by (Aspergillus, Candida , Cryptococcus, histoplasma)
- given by slow I.V.
Amphotericin Toxicity?
Nephrotoxicity is dose limiting
Neurotoxicity
infusion rxn ( chills, fever, muscle spasm, hypotension)
Amphotericin B I.V. Infusion related toxicity?
- fever
- chills
- muscle spasms
- vomiting
- hypotension (shock-like fall in blood pressure)
- effects can be attenuated by: slow infusion rate and premedication with antihistamines, antipyretics, glucocorticoids*
Amphotericin B dose limiting toxicity?
- decreases the GFR + RTA renal tubular acidosis (with magnesium and potassium wasting)
- Anemia: decrease of erythropoietin formation
- Liposomal formulations have reduced nephrotoxic effects
Amphotericin B Neurotoxicity toxicity?
Intrathecal administration –> seizures and neurologic damage
what about Flucytosine?
pyrimidine antimetabolite related to the anticancer 5-FU
Flucytosin PharmacoKinetix?
- Bioavailability: effective orally
- distribution: most body (also CNS)
- Elemination: intact in the urine
(dose must be reduced in patients with renal impairment)
Flucytosine MOA?
Inhibits DNA , RNA polymerases
- membrane permease –> accumulate the drug in fungal cells –> converted by cytosine deaminase to –> 5-FU –> inhibits thymidylate synthase
- Resistance can occur rapidly if flucytosine is used alone
- When 5-FC is given with amphotericin B/ itraconazole –> emergence of resistance is decreased and synergistic antifungal effects may occur
Flucytosine clinical uses?
- antifungal spectrum of 5-FC is narrow
- limited to the treatment in combination with amphotericin B / itraconazole
- used against:
1. synergistic with Amphotericin B in Candidemia , cryptococcus neoformans
2. molds (for chromoblastomycosis)
Flucytosine Toxicity?
- Prolonged high plasma LvLs:
1. reversible bone marrow depression
2. alopecia
3. liver dysfunction.
Azole Antifungal agents?
FIV(5)
- Fluconazol
- Itraconazol
- Voriconazol
- Clotrimazole